Another Infliximab Biosimilar On Horizon In India?

 
• By Anju Ghangurde
Eclipse
BIOCAD'S INFLIXIMAB HAS RECEIVED A KEY APPROVAL IN INDIA BUT LAUNCH PLANS ARE HAZY • Source: Shutterstock

More from India

More from Focus On Asia